Size of stage IIIA primary lung cancers and survival: A surveillance, epidemiology and end results database analysis

American Surgeon

Volumn 78, Issue 11, 2012, Pages 1232-1237

  Maximus, Steven ^a   Nguyen, Danh V ^b   Mu, Yi ^b   Calhoun, Royce F ^a   Cooke, David T ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CANCER GRADING; CANCER PROGNOSIS; CANCER STAGING; COHORT ANALYSIS; DATA BASE; FEMALE; HUMAN; LUNG LOBECTOMY; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; RETROSPECTIVE STUDY; SEX DIFFERENCE; SURVIVAL PREDICTION; TUMOR LOCALIZATION; TUMOR VOLUME;

AGED; CARCINOMA, NON-SMALL-CELL LUNG; COHORT STUDIES; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; RETROSPECTIVE STUDIES; SEER PROGRAM; SURVIVAL RATE; TUMOR BURDEN;

EID: 84867905836     PISSN: 00031348     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Goldstraw P, Crowley J, Chansky K, et al. The IASLC lung cancer staging project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours. J Thorac Oncol 2007;2:1067-77.
2. American Joint Committee on Cancer. Thorax. In: Edge SB, Byrd DR, Compton CC, et al., eds. AJCC Cancer Staging Manual. 7th Ed. New York, NY: Springer 2009:251-78.
3. Saito M, Harubumi K. Prognostic factors in patients with pathological and N2 non-small cell lung cancer. Ann Thorac Cardiovasc Surg 2008;14:1-2.
4. Goldstraw P, Mannam GC, Kaplan DK, et al. Surgical management of non-small cell lung cancer with ipsilateral mediastinal node metastasis (N2 disease). J Thorac Cardiovasc Surg 1994;107:19-28. (Pubitemid 24050494)
5. Martini N, Flehinger BJ. The role of surgery in N2 lung cancer. Surg Clin North Am 1987;67:1037-49. (Pubitemid 17158584)
6. Watanabe Y, Shimizu J, Oda M, et al. Aggressive surgical intervention in N2 nonsmall cell cancer of the lung. Ann Thorac Surg 1991;51:253-61.
7. Vansteenkiste JF, De Leyn PR, Deneffe GJ, et al. Survival and prognostic factors in resected N2 non-small cell lung cancer: a study of 140 cases. Ann Thorac Surg 1997;63:1441-50. (Pubitemid 27239740)
8. Asamura H, Nakayama H, Kondo H, et al. Lobe-specific extent of systemic lymph node dissection for non-small cell lung carcinomas according to a retrospective study of metastasis and prognosis. J Thorac Cardiovasc Surg 1999;117:1102-11. (Pubitemid 29270349)
9. Vansteenkiste JF, De Leyn PR, Deneffe GJ, et al. Clinical prognostic factors in surgical treated stage IIIA-N2 non-small cell lung cancer: analysis of the literature. Lung Cancer 1998;19:3-13. (Pubitemid 28044078)
10. National Cancer Institute. Surveillance Epidemiology and End Results. Available at: http://seer.cancer.gov/. Accessed July 5, 2011.
11. Tanaka F, Yanagihara K, Otake Y, et al. Prognostic factors in resected pathologic (p-) stage IIIA-N2, non-small-cell lung cancer. Ann Surg Oncol 2004;11:612-8. (Pubitemid 40486719)
12. Meacci E, Cesario A, Cusumano G, et al. Surgery for patients with persistent pathological N2 IIIA stage in non-small-cell lung cancer after induction radio-chemotherapy: the microscopic seed of doubt. Eur J Cardiothorac Surg 2011;40:656-63.
13. Suzuki K, Nagai K, Yoshida J, et al. The prognosis of surgically resected N2 non-small cell lung cancer: the importance of clinical N status. J Thorac Cardiovasc Surg 1999;118:145-53. (Pubitemid 29321009)
14. Régnard JF, Magdeleinat P, Azoulay D, et al. Results of resection for bronchogenic carcinoma with mediastinal lymph node metastases in selected patients. Eur J Cardiothorac Surg 1991;5:583-7.
15. Martini N, Flehinger BJ, Zaman MB, et al. Results of resection in non-oat cell carcinoma of the lung with mediastinal lymph node metastases. Ann Surg 1983;198:386-97. (Pubitemid 13050832)
16. Inoue M, Sawabata N, Takeda S, et al. Results of surgical intervention for p-stage IIIA (N2) non-small cell lung cancer: acceptable prognosis predicted by complete resection in patients with single N2 disease with primary tumor in the upper lobe. J Thorac Cardiovasc Surg 2004;127:1100-6. (Pubitemid 38451944)
17. Casali C, Stefani A, Natali P, et al. Prognostic factors in surgically resected N2 non-small cell lung cancer: the importance of patterns of mediastinal lymph nodes metastases. Eur J Cardiothorac Surg 2005;28:33-8. (Pubitemid 40883928)
18. Andre F, Grunenwald D, Pignon JP, et al. Survival of patients with resected N2 non-small cell lung cancer: evidence for a subclassification and implications. J Clin Oncol 2000;18:2981-9. (Pubitemid 30644122)
19. Ichinose Y, Kato H, Koike T, et al. Japanese Clinical Oncology Group. Completely resected stage IIIA non-small cell lung cancer: the significance of primary tumor location and N2 station. J Thorac Cardiovasc Surg 2001;122:803-8.
20. Misthos P, Sepsas E, Athanassiadi K, et al. Skip metastases: analysis of their clinical significance and prognosis in the IIIA stage of non-small cell lung cancer. Eur J Cardiothorac Surg 2004;25:502-8. (Pubitemid 38376060)
21. Liu K, Chen HL, You QS, et al. Clinical analysis of skip N2 metastases in stage IIIA non-small cell lung cancer. Ai Zheng 2009;28:725-9.
22. Robinson LA, Ruckdeschel JC,Wagner H Jr, et al. American College of Chest Physicians. Treatment of non-small cell lung cancer-stage IIIA: ACCP Evidence-Based Clinical Practice Guidelines (2nd Edition). Chest 2007;132:243S-65S. (Pubitemid 47502811)